EU & ESGBased on the new regulations in the EU, companies are getting backed into a corner to comply to all the regulations on ESG. https://plana.earth/academy/eu-esg-regulations
If you are a big pharma manufacturing company in Europe, (12 of the top 15 drug exporters are in EU), would you not look at Voyageur ESG carbon capture, and buy them out just so you can continue to operate under the tightening ESG reguations? The value of Voy ESG is big, and has not been factored into anything they are doing. Well niether has the FC project, HC licenses, $2.6M contract, etc etc. Whitenorth is right, time to pivot out of the tsxv.
If you have a verified sustainable product, in the EU, it goes to the top of the bid list. The Canadian government is also pushing this ESG onto sustainable products to rise to the top of provincial healthcare bids.